Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p24
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 24/381)
Character Range: 11624003–11633176

form(s); and
                                                                                                                                                                    (b) a completed Severe Chronic Plaque Psoriasis PBS Authority Application - Supporting Information Form which includes the completed current Psoriasis Area and Severity Index (PASI) calculation sheets including the dates of assessment of the patient's condition.
                                                                                                                                                                    To demonstrate a response to treatment the application must be accompanied with the assessment of response, conducted following a minimum of 12 weeks of therapy and no later than 4 weeks from cessation of the most recent course of biological medicine. It is recommended that an application for the continuing treatment be submitted no later than 4 weeks from the date of completion of the most recent course of treatment. This is to ensure treatment continuity for those who meet the continuing restriction.
                                                                                                                                                                    Where a response assessment is not conducted within the required timeframe, the patient will be deemed to have failed to respond to treatment with this drug, unless the patient has experienced a serious adverse reaction of a severity resulting in the necessity for permanent withdrawal of treatment.
                                                                                                                                                                    If a patient fails to demonstrate a response to treatment with this drug under this restriction they will not be eligible to receive further PBS-subsidised treatment with this drug for this condition within this treatment cycle.
C10748              P10748         CN10748          Buprenorphine                                                                                                   Chronic severe pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Compliance with Authority Required procedures - Streamlined Authority Code 10748
                                                                                                                                                                    Initial PBS treatment after 1 June 2020 where patient has been treated with opioids for more than 12 months
                                                    Morphine                                                                                                        The condition must require daily, continuous, long term opioid treatment; AND
                                                                                                                                                                    Patient must have cancer pain.  or
                                                    Oxycodone                                                                                                       Patient must have had or would have inadequate pain management with maximum tolerated doses of non-opioid or other opioid analgesics.  or
                                                                                                                                                                    Patient must be unable to use non-opioid or other opioid analgesics due to contraindications or intolerance.
                                                    Oxycodone with naloxone                                                                                         Palliative care nurses may conduct annual review under this item for the treatment of palliative care patients only.

                                                    Tapentadol

                                                    Tramadol

C10752              P10752         CN10752          Buprenorphine                                                                                                   Chronic severe pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Compliance with Authority Required procedures - Streamlined Authority Code 10752
                                                                                                                                                                    Continuing PBS treatment after 1 June 2020
                                                    Morphine                                                                                                        Patient must have previously received PBS-subsidised treatment with this form of this drug for this condition after 1 June 2020.
                                                                                                                                                                    Palliative care nurses may conduct annual review under this item for the treatment of palliative care patients only.
                                                    Oxycodone

                                                    Oxycodone with naloxone

                                                    Tapentadol

                                                    Tramadol

C10755              P10755         CN10755          Buprenorphine                                                                                                   Chronic severe pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Compliance with Authority Required procedures - Streamlined Authority Code 10755
                                                                                                                                                                    Initial PBS treatment after 1 June 2020 where patient has been treated with opioids for less than 12 months
                                                    Morphine                                                                                                        The condition must require daily, continuous, long term opioid treatment; AND
                                                                                                                                                                    Patient must have cancer pain.  or
                                                    Oxycodone                                                                                                       Patient must have had or would have